| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is making notable strides in Product/Service Development, with a strong focus on innovative therapies and significant investments to enhance its market offerings. The successful late-stage trials for Zepbound and the promising potential of tirzepatide underscore the company's commitment to addressing chronic health conditions, particularly in the weight loss and arthritis sectors. Additionally, leveraging AI in drug discovery presents a modern approach to speeding up the development process. While optimism around product approvals and innovations remains high, continuous monitoring of market dynamics and competition is essential. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 0.2 is modestly bullish. The market sentiment at 1.3 is very bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.LLY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.3, and the negative at -0 on 2026-01-13. The forces of Sentiment towards Fundamentals (4.1), Valuation Sentiment (1.7), Market Risk Appetite (0.9), Option Sentiment (0.8), Stock Price Trend (0.2), and Price Level Sentiment (0) will drive up the price. The forces of and Sector Price Trend (-0.4) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-13 | 0%(0%) | 1076.63 | 59 | -0.37% | -0.03% | 0.2 | -0.01% | 0.5% | 1.3 | Wait | 50% | 4.1 | 6.5 |
| 2026-01-12 | 0%(0.1%) | 1080.58 | 67 | 1.61% | 0.03% | 0.9 | -0.06% | 0.8% | 1.1 | Long | 65% | 4 | 7 |
| 2026-01-11 | 0%(0.1%) | 0.3 | -0.19% | 0.9 | 3.4 | -1 | |||||||
| 2026-01-10 | 0%(0.1%) | 0.3 | -0.19% | 0.7 | 3.4 | -1 | |||||||
| 2026-01-09 | 0%(0.1%) | 1063.48 | 48 | -2% | -0.12% | 0.3 | -0.19% | 1.3% | 0.7 | Short | 65% | 3.1 | -1 |
| 2026-01-08 | 0%(0.1%) | 1085.14 | 72 | -2.08% | 0.13% | 0.6 | 0.16% | 1.6% | 0.9 | Long | 65% | 3.3 | -1 |
| 2026-01-07 | 0%(0.1%) | 1108.14 | 91 | 4.16% | 0.3% | 0.8 | 0.33% | 2.4% | 0.7 | Wait | 50% | 3.2 | 6.5 |
| 2026-01-06 | 1%(0.3%) | 1063.88 | 60 | 2.15% | -0.07% | 0.2 | -0.03% | 1.3% | 0.8 | Wait | 50% | 2.9 | 5.7 |
| 2026-01-05 | 0%(0.1%) | 1041.44 | 45 | -3.6% | -0.14% | -0.1 | -0.18% | 1.6% | 0.4 | Short | 65% | 1.4 | 1 |
| 2026-01-04 | 0%(0.1%) | 0.4 | 0.1% | 0.4 | 1.8 | -1 | |||||||
| Wait is the preferred trading strategy with 50% chance of being right. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2026-01-13 17:02:25 Forecasts regarding Eli Lilly's potential market value have prospects of reaching significant milestones in the coming years. |
| 2026-01-13 17:02:25 Eli Lilly's ongoing product development, particularly regarding their obesity pill, showcases their commitment to innovation in health. |
| 2026-01-13 17:02:25 Eli Lilly's CEO discusses the company's strategic direction and leadership in the pharmaceutical industry. |
| 2026-01-13 17:02:25 The competition between Eli Lilly and Novo Nordisk in the weight loss drug sector is intensifying, affecting market dynamics for future drug sales. |
| 2026-01-13 17:02:25 Recent trading performance of Eli Lilly stock has shown positive movement, indicating investor confidence. |
| 2026-01-13 15:49:43 Eli Lilly's optimism regarding the approval of their weight-loss pill in the US indicates positive expectations about product development timelines and potential market impact. |
| 2026-01-13 15:49:43 The competition between Eli Lilly and Novo Nordisk in the weight-loss pill market highlights the ongoing rivalry among pharmaceutical companies in this lucrative segment. |
| 2026-01-13 15:49:43 The increasing demand for weight-loss medications and the anticipated global market penetration of Eli Lilly's new pill reflect a significant trend in the health and wellness industry. |
| 2026-01-13 13:49:38 Investments made by Eli Lilly in new technologies to foster growth and innovative solutions. |
| 2026-01-13 13:49:38 The strategic partnership between Eli Lilly and Nvidia aimed at innovation and development within pharmaceutical applications. |
| 2026-01-13 13:49:38 The focus on leveraging AI technologies to enhance the process of drug discovery in the pharmaceutical industry. |